The UK Department of Health has announced (PDF) that the human papillomavirus vaccination programme is to be extended to include young women aged 17-18.
The decision to use Cervarix® has been criticised but this announcement does start to explain why the programme is using an apparently inferior vaccine.
Hat tip: http://www.prescriber.org.uk/
No comments:
Post a Comment